Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFP Peptide Immunization in Hepatocellular Carcinoma
NCT00005629Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jul 1999
- Primary completion
- May 2002
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of AFP gene hepatocellular carcinoma vaccine in hepatocellular carcinoma (HCC), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Jul 1999; status: completed.
02
Drugs
AFP gene hepatocellular carcinoma vaccine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00005629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005629.